BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durczynski A, Kumor A, Hogendorf P, Szymanski D, Grzelak P, Strzelczyk J. Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer. World J Gastroenterol 2014; 20(36): 13167-13171 [PMID: 25278712 DOI: 10.3748/wjg.v20.i36.13167] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Feng JF, Yang X, Chen S, Zhao Q, Chen QX. Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China. J Cancer 2016;7:1663-7. [PMID: 27698903 DOI: 10.7150/jca.15216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
2 Marchetti M, Falanga A. Hemostatic biomarkers in occult cancer and cancer risk prediction. Thromb Res 2020;191 Suppl 1:S37-42. [PMID: 32736777 DOI: 10.1016/S0049-3848(20)30395-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu P, Zhu Y, Liu L. Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma. Onco Targets Ther. 2015;8:1335-1340. [PMID: 26082650 DOI: 10.2147/ott.s82329] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
4 Durczynski A, Skulimowski A, Hogendorf P, Szymanski D, Kumor A, Marski K, Juliebø SØ, Poznanska G, Strzelczyk J. The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer. World J Surg Oncol 2017;15:223. [PMID: 29246148 DOI: 10.1186/s12957-017-1291-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
5 Liu X, Fu Y, Chen Q, Wu J, Gao W, Jiang K, Miao Y, Wei J. Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer. BMC Gastroenterol 2018;18:168. [PMID: 30400836 DOI: 10.1186/s12876-018-0891-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
6 Jimenez-Luna C, Torres C, Ortiz R, Dieguez C, Martinez-Galan J, Melguizo C, Prados JC, Caba O. Proteomic biomarkers in body fluids associated with pancreatic cancer. Oncotarget. 2018;9:16573-16587. [PMID: 29662668 DOI: 10.18632/oncotarget.24654] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
7 Moik F, Prager G, Thaler J, Posch F, Wiedemann S, Schramm T, Englisch C, Mackman N, Pabinger I, Ay C. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer. Arterioscler Thromb Vasc Biol 2021;41:2837-47. [PMID: 34470475 DOI: 10.1161/ATVBAHA.121.316463] [Reference Citation Analysis]
8 Chen C, Li J, Li J, Wang X, Wang X, Du N, Ren L. Application of an elevated plasma D-dimer cut-off value improves prognosis prediction of advanced non-small cell lung cancer. Ann Transl Med 2020;8:1153. [PMID: 33241002 DOI: 10.21037/atm-20-5947] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Mattila N, Seppänen H, Mustonen H, Przybyla B, Haglund C, Lassila R. Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma. Clin Appl Thromb Hemost 2018;24:1267-75. [PMID: 29865859 DOI: 10.1177/1076029618779133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 González-Borja I, Viúdez A, Goñi S, Santamaria E, Carrasco-García E, Pérez-Sanz J, Hernández-García I, Sala-Elarre P, Arrazubi V, Oyaga-Iriarte E, Zárate R, Arévalo S, Sayar O, Vera R, Fernández-Irigoyen J. Omics Approaches in Pancreatic Adenocarcinoma. Cancers (Basel) 2019;11:E1052. [PMID: 31349663 DOI: 10.3390/cancers11081052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Durczynski A, Kumor A, Grzelak P, Strzelczyk M, Hogendorf P, Poznanska G, Skulimowski A, Szymanski D, Strzelczyk J. Concentration of D-dimers in Bile-a Novel Marker of Pancreatic Cancer Enhancing Accuracy of Standard CA19-9 Measurement: Dual Test Hypothesis. Pancreas 2017;46:e9-e10. [PMID: 27763956 DOI: 10.1097/MPA.0000000000000696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Cao J, Fu Z, Gao L, Wang X, Cheng S, Wang X, Ren H. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma. World J Surg Oncol 2017;15:48. [PMID: 28219450 DOI: 10.1186/s12957-017-1104-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
13 Pereira CF, Sales MGF, Frasco MF. A molecularly imprinted photonic polymer based on an inverse opal structure for sensing D-dimer at the point-of-care. Talanta 2022;243:123387. [DOI: 10.1016/j.talanta.2022.123387] [Reference Citation Analysis]
14 Faille D, Bourrienne MC, de Raucourt E, de Chaisemartin L, Granger V, Lacroix R, Panicot-Dubois L, Hammel P, Lévy P, Ruszniewski P, Ajzenberg N, Rebours V. Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process. Oncotarget 2018;9:26453-65. [PMID: 29899870 DOI: 10.18632/oncotarget.25458] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
15 Diab HMH, Smith HG, Jensen KK, Jørgensen LN. The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic review. Eur J Cancer 2021;154:73-81. [PMID: 34243080 DOI: 10.1016/j.ejca.2021.05.033] [Reference Citation Analysis]
16 Strzałka A, Hogendorf P, Skulimowski A, Spychalski M, Strzelczyk J, Durczynski A. Thyroid hormones concentration in portal and peripheral blood in patients with pancreatic cancer: Preliminary study. Cancer Biomark 2020;29:301-6. [PMID: 32568183 DOI: 10.3233/CBM-201595] [Reference Citation Analysis]
17 Szmiel A, Majos A, Ciesielski W, Kumor A, Strzelczyk J, Szwedziak K, Hogendorf P, Durczyński A. Gender-Specific Coagulation Profiles of Peripheral and Portal Blood May Help to Differentiate Malignant from Benign Pancreatic Tumour—Pilot Study. JCM 2022;11:1573. [DOI: 10.3390/jcm11061573] [Reference Citation Analysis]
18 Chen H, Li F, Zou S, Xie J, Zhang J, Deng X, Chen H, Shen B. Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection. World J Surg Oncol 2021;19:166. [PMID: 34107980 DOI: 10.1186/s12957-021-02281-8] [Reference Citation Analysis]
19 Yu J, Li D, Lei D, Yuan F, Pei F, Zhang H, Yu A, Wang K, Chen H, Chen L, Wu X, Tong X, Wang Y. Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study. PLoS One 2016;11:e0165390. [PMID: 27835633 DOI: 10.1371/journal.pone.0165390] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]